新光药业 (300519.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(新光药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 100,545,259.30270,399,837.67216,113,933.59149,038,556.1092,296,717.31351,488,810.60262,451,469.03170,464,124.83101,895,419.99
 营业利润(元) 26,008,191.4974,133,032.3870,078,037.7945,334,468.2935,849,891.37126,604,501.73105,920,606.2171,450,894.5150,323,415.18
 利润总额(元) 26,189,965.4973,160,104.3469,086,037.7945,342,468.2935,857,891.37125,603,566.19104,919,670.6771,449,958.9750,336,379.64
 净利润(元) 22,830,341.3664,356,480.6558,699,769.3838,539,667.0030,445,257.47108,821,010.0689,396,702.1460,804,863.6642,819,141.85
 归属于母公司股东的净利润(元) 22,830,341.3664,356,480.6558,699,769.3838,539,667.0030,445,257.47108,821,010.0689,396,702.1460,804,863.6642,819,141.85
盈利能力:
 销售毛利率(%) 37.5341.2745.1246.9251.1551.8554.2654.4957.18
 销售净利率(%) 22.7123.8027.1625.8632.9930.9634.0635.6742.02
 净资产收益率(%) 2.607.567.004.733.42----
 总资产报酬率ROA(%) 2.555.756.074.743.56----
 投入资本回报率ROIC(%) 2.677.566.924.603.4812.7610.617.344.93
营运能力:
 存货周转率(次) 1.402.702.261.531.08----
 应收账款周转率(次) 12.5116.0011.3411.4610.20----
 总资产周转率(次) 0.110.290.230.170.10----
偿债能力:
 资产负债率(%) 8.279.278.848.727.5610.329.3210.009.18
 股东权益比率(%) 91.7390.7391.1691.2892.4489.6890.6890.0090.82
 已获利息倍数(倍) -12.86-2.87-4.29-15.70-26.82-11.86-11.38-8.39-6.84
 流动比率 11.5410.1910.9211.0913.119.1910.289.4710.46
 速动比率 10.769.2310.0210.2712.398.649.638.819.86
发展能力:
 营业收入增长率(%) 8.94-23.07-17.66-12.57-9.429.546.576.876.01
 营业利润增长率(%) -27.45-41.45-33.84-36.55-28.76-4.51-1.216.639.72
 税后利润增长率(%) -25.01-40.86-34.34-36.62-28.90-4.781.616.659.85
 净资产增长率(%) -2.58-1.72-0.150.830.031.502.442.902.68
 总资产增长率(%) -1.81-2.86-0.68-0.58-1.732.724.206.295.41

前瞻产业研究院